Voyager Therapeutics, Inc. · NASDAQ:VYGR
Armistice Capital, LLC reported a 5.58% stake in Voyager Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 5.58% stake in Voyager Therapeutics, Inc., 3,436,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.58%
- Shares
- 3,436,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 5.58% | 3,436,000 |
| Steven Boyd | 5.58% | 3,436,000 |
Source
Related
- Voyager Therapeutics, Inc.
- Armistice Capital, LLC
- Voyager Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Nov 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 31, 2026
- Schedule 13G/A · EcoR1 Capital, LLC · May 15, 2026
- Form 4 · Sandrock Alfred · Apr 3, 2026
- Form 4 · Shiferman Gregory L. · Apr 3, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026